BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
HealthDay News — Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individuals undergoing lung cancer screening (LCS); however, adherence rates ...
News-Medical.Net on MSN1d
Over 3.8 million lung cancer deaths prevented in the United States due to smoking declineNew research led by American Cancer Society (ACS) researchers estimates more than 3.8 million lung cancer deaths were averted ...
Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...
Emerging data suggest that SBRT may be comparable with surgery for definitive treatment of stage I NSCLC in certain patients. When is one approach preferred and in whom?
Adherence to annual lung cancer screening declines over time, with lower adherence linked to reduced lung cancer detection ...
Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion.
Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit ...
In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback